乳腺癌患者的创伤后生长经验:定性系统性审查和元合成
ShiNi Huang1, Min Huang2, Fang Long1
1Department of Nursing, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.
PloS one
|January 23, 2025
概括
乳腺癌幸存者经历了显著的创伤后成长,包括自我重建和增强的灵性. 医疗保健提供者应支持患者.
科学领域:
- 在瘤学瘤学.
- 心理学 心理学 心理学
- 定性研究是指质量研究.
背景情况:
- 系统性审查登记:CRD42024519850.0. 系统性审查登记:CRD42024519850. 系统性审查登记:CRD42024519850. 系统性审查登记:CRD42024519850. 系统性审查登记:CRD42024519850. 系统性审查登记:CRD42024519850.
- 乳腺癌幸存者经常报告创伤后生长 (PTG).
- 了解PTG对于开发有效的心理干预至关重要.
研究的目的:
- 系统地综合乳腺癌患者的创伤后生长经验.
- 确定在这个人群中对PTG有所贡献的关键主题和因素.
- 为制定有针对性的心理护理策略提供信息.
主要方法:
- 系统搜索11个中英文数据库 (截至2024年2月).
- 包括关于乳腺癌患者PTG经验的定性研究.
- 乔安娜·布里格斯研究所 (JBI) 的元整合方法,遵循PRISMA和ENTREQ的指导方针.
主要成果:
- 11项研究产生了42个主题和68个子主题.
- 四个整合性结论出现了:自我重建,增强的灵性/宗教信仰,新的生活哲学欣赏,以及人际转变.
- 这些发现突出了PTG的多方面的方面.
结论:
- 医疗专业人员需要清楚地了解PTG.
- 鼓励刻意反省,情绪释放和有效应对至关重要.
- 加强社会支持系统可以促进PTG并改善患者的福祉.
更多相关视频
07:14A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
Published on: January 18, 2018
9.3K
10:10Long-term Culture of Human Breast Cancer Specimens and Their Analysis Using Optical Projection Tomography
Published on: July 29, 2011
15.2K
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Cancer Survival Analysis
327
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
327
